1. Positioning glucagonlike-peptide-1-based treatments within an optimal management regimen for type 2 diabetes;Hansen;European Journal of Endocrinology. Supplement,2008
2. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency;Alavi;Mol. Pharm.,2019
3. DPP-4 inhibitors;Ahrén;Best Pract. Res. Clin. Endocrinol. Metabol.,2007
4. Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist;Hall;Clin. Pharmacokinet.,2018
5. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence;Meloni;Diabetes Obes. Metabol.,2013